Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.45 |
| ▸ | PIN1 | Q13526 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1080850 | 0.87 | PIN1 (0.47) | ALOX15PIN1KDM4ETDP1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL6861539 | 0.85 | PIN1 (0.46) | ALOX15PIN1KDM4ETDP1SMN1; SMN2 | |
| SCHEMBL1079995 | 0.85 | ALDH1A1 (0.49) | HSD17B10PIN1KDM4ECYP1A2MAPK1 | |
| SCHEMBL10556437 | 0.84 | HSD17B1 (0.46) | ALOX12ALDH1A1GAAHPGDADORA2A | |
| SCHEMBL8963515 | 0.84 | NISCH (0.42) | ADORA3KDM4ESMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL6861535 | 0.84 | PIN1 (0.41) | MAPTADORA3PIN1CYP1A2MAPK1 | |
| SCHEMBL25413935 | 0.83 | PIN1 (0.52) | NPSR1ADORA3PIN1KDM4EALDH1A1 | |
| SCHEMBL1313241 | 0.83 | ERCC1 (0.50) | HSD17B10KDM4ESMN1; SMN2ALDH1A1GAA | |
| SCHEMBL20647119 | 0.83 | PIN1 (0.41) | MAPTADORA3PIN1SMN1; SMN2CYP1A2 | |
| SCHEMBL17321497 | 0.83 | PIN1 (0.41) | MAPTADORA3PIN1SMN1; SMN2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119307169-A | Curable composition, cured product, overcoat film for flexible wiring board, and method for producing flexible wiring board | 日保丽公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-114072444-B | Curable composition, cured product, overcoat film, flexible wiring board, and method for producing same | 日保丽公司 | 2024-07-09 | — | — | CN | disclosed |
| EP-3395848-B1 | POLYURETHANE, CURABLE COMPOSITION, OVERCOAT FILM, AND FLEXIBLE WIRING BOARD AND PRODUCTION METHOD THEREFORE | NIPPON POLYTECH CORP (JP) | 2024-02-28 | — | — | EP | disclosed |
| CN-114080408-B | Cured product, overcoat film, and flexible wiring board | 日保丽公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-114096579-B | Polyurethane and curable composition | 日保丽公司 | 2023-06-09 | — | — | CN | disclosed |
| WO-2022272106-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2022-12-29 | — | — | WO | disclosed |
| CN-114096579-A | Polyurethane and curable composition | 日保丽公司 | 2022-02-25 | — | — | CN | disclosed |
| CN-114080408-A | Cured product, overcoat film, and flexible wiring board | 日保丽公司 | 2022-02-22 | — | — | CN | disclosed |
| CN-114072444-A | Curable composition, cured product, overcoat film, flexible wiring board, and method for producing same | 日保丽公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-109071954-B | Curable composition, cured film using same, and overcoat film | 日保丽公司 | 2021-11-02 | — | — | CN | disclosed |
| EP-2390276-A1 | CARBOXYL GROUP-CONTAINING POLYURETHANE | Showa Denko K.K. (JP) | 2011-11-30 | — | — | EP | disclosed |
| EP-2390277-A1 | (POLY)CARBONATE POLYOL AND CARBOXYL GROUP-CONTAINING POLYURETHANE USING THE (POLY)CARBONATE POLYOL AS STARTING MATERIAL | Showa Denko K.K. (JP) | 2011-11-30 | — | — | EP | disclosed |
| US-20110272183-A1 | (POLY)CARBONATE POLYOL AND CARBOXYL GROUP-CONTAINING POLYURETHANE OBTAINED FROM THE (POLY)CARBONATE POLYOL | SHOWA DENKO K.K. (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110272182-A1 | CARBOXYL GROUP-CONTAINING POLYURETHANE | SHOWA DENKO K.K. (JP) | 2011-11-10 | — | — | US | disclosed |
| EP-2383310-A1 | CURABLE COMPOSITION | Showa Denko K.K. (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-20110253426-A1 | CURABLE COMPOSITION | SHOWA DENKO K.K. (JP) | 2011-10-20 | — | — | US | disclosed |
| US-20110257257-A1 | COMPOSITION FOR TREATMENT OF EPITHELIAL TISSUE | NOVODERMIX INTERNATIONAL LIMITED (VG) | 2011-10-20 | — | — | US | disclosed |
| US-RE30511-E | ENZYME INHIBITOR, HERBICIDE, CYCLIZATION | AMERICAN CYANAMID COMPANY (US) | 1981-02-10 | — | — | US | disclosed |
| US-4168964-A | HERBICIDES | AMERICAN CYANAMID COMPANY (US) | 1979-09-25 | — | — | US | disclosed |
| US-4107307-A | ENZYME INHIBITORS, HERBICIDES, RING CLOSURE | AMERICAN CYANAMID COMPANY (US) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110272183-A1 | (POLY)CARBONATE POLYOL AND CARBOXYL GROUP-CONTAINING POLYURETHANE OBTAINED FROM THE (POLY)CARBONATE POLYOL | PUF60, PARG, PIK3C2G | MAPT 3516/4885ALOX12 1053/4885ALOX15 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.